bpc-157 fda ind or nda to Reconsider and Other Peptides | Ashish Talati posted on the topic The date is locked in
The date is locked in for LGMD2I R9. The FDA has accepted our NDA for BBP 418 for LGMD2I R9, with a PDUFA target action date of November 27, 2026. For a community that has BPC 157 FDA Approval Status: Is It Approved for Human Use? Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest New FDA Forms for INDs, NDAs, and BLAs: What to Know Before Submitting DocShifter
Pay in 4 interest-free payments of $7.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


